When GBM cells stably overexpressing CSRP2 were treated with the NF-κB inhibitor JSH 23, cell proliferation (Fig. 5A, B), colony formation (Fig. 5C, D), cell migration (Fig. 5E, F), and cell invasion (Fig. 5G, H) were all reduced. The gene discussed is CSRP2; the disease is glioblastoma.